SCHEMBL6718152

SCHEMBL6718152

CCCCC(Cc1ccc(OCCNC(=O)c2cnc3ccccc3c2)cc1)C(=O)O.[NaH]

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 6/20 0.49
PTGES O14684 4/20 0.49
ALOX5 P09917 4/20 0.49
PPARA Q07869 2/20 0.49
HDAC3 O15379 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC2 Q92769 1/20 0.48
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
ITGB1 P05556 1/20 0.47
ITGA4 P13612 1/20 0.47
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
GCGR P47871 2/20 0.45
HPGDS O60760 1/20 0.44
TRPV1 Q8NER1 1/20 0.42
ADCY6 O43306 1/20 0.42
ADCY3 O60266 1/20 0.42
ADCY9 O60503 1/20 0.42
ADCY5 O95622 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6718155 0.98 PPARG (0.49) PPARGPTGESALOX5PPARAHDAC3
SCHEMBL6718154 0.91 HDAC3 (0.47) PPARGPTGESALOX5PPARAHDAC3
SCHEMBL6716167 0.91 HDAC3 (0.47) PPARGPTGESALOX5PPARAHDAC3
SCHEMBL6715196 0.82 PPARG (0.51) PPARGPTGESALOX5PPARANPC1
SCHEMBL6714929 0.82 PPARG (0.52) PPARGPTGESALOX5PPARANPC1
Diethylamine SCHEMBL6805517 0.82 NPC1 (0.55) PPARGPTGESALOX5PPARANPC1
SCHEMBL6718066 0.82 NPC1 (0.58) PPARGPTGESALOX5PPARANPC1
SCHEMBL6716004 0.80 PPARG (0.52) PPARGPTGESALOX5PPARANPC1
SCHEMBL6715078 0.79 PPARG (0.50) PPARGPTGESALOX5PPARANPC1
SCHEMBL6715733 0.78 PPARG (0.51) PPARGPTGESALOX5PPARANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040006141-A1 Amidocarboxylic acid compounds SANKYO COMPANY, LTD (JP) 2004-01-08 US disclosed
US-6528525-B1 Amidocarboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2003-03-04 US disclosed
EP-1026149-A1 AMIDOCARBOXYLIC ACID DERIVATIVES Sankyo Company Limited (JP) 2000-08-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006141-A1 Amidocarboxylic acid compounds NR1H2, AGK, APOL1 PPARG 23/4885PTGES 547/4885ALOX5 59/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.